This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
I worked closely with NCI’s Investigational Drug Branch (IDB) from 1990-2016, including as a principal investigator of one of only six contracts with NCI to conduct Phase 1 clinical trials from 1990-1995, and serving as co-chair of NCI’s Investigational Drug Steering Committee from 2005-2008. At this stage, U.S.
External Links Medical Genetics Summaries Clinical Pharmacogenetics Implementation Consortium Pharmacogenetics of warfarin: regulatory, scientific, and clinical issues, 2008 HLA-B*5701 screening for hypersensitivity to abacavir, 2008 Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations, (..)
ART-123 is a recombinant human thrombomodulin (rTM) approved in Japan in 2008. There are currently no drugs showing clear, established effectiveness for the prevention or treatment of CIPN, leaving patients with limited, often undesirable options.
This commitment, combined with her vision and leadership, led to the launch of PolicyMap in 2008. Drawing on her career in city, state, and federal government, McCullough has dedicated her work to making complex information accessible and actionable.
Nick took over in 2008 after finishing his pharmacy degree. So, I worked at Bova for 16 years in Australia. I launched the expansion of the company with Nick Bova, the owner, so you could say I was employee number one, I suppose. I started the same year, and we built the business in Australia from there.
Teva Pharmaceuticals IV Saline Contamination (USA, 2008) Contaminated sodium chloride IV solutions resulted in fatal endotoxin reactions in hospitalized patients. The company had falsified sterility test results and manufactured under unqualified cleanroom conditions.
International Council for Harmonisation (ICH), 2008. International Council for Harmonisation (ICH), 2009. Q8(R2) Pharmaceutical Development. International Council for Harmonisation (ICH), 2005. Q9 Quality Risk Management. Q10 Pharmaceutical Quality System. International Council for Harmonisation (ICH), 2012.
Eligible patients include adults (≥ 18 years) diagnosed with CML receiving imatinib as first-line therapy for more than 1 month between 2008 and 2023. Materials and Methods This retrospective observational study utilized the Carolina Data Warehouse for Health electronic health record (EHR) database.
Discovered and developed by MSD Pharmaceuticals, Sitagliptin was the first DPP4i introduced in India in 2008. Sitagliptin belongs to the class of Dipeptidyl Peptidase IV Inhibitors (DPP4i) and is used in the treatment of Type 2 diabetes. Despite the loss of exclusivity, the portfolio continues to be among the leaders in its category.
External Links American Academy of Dermatology Association - Cold Sores Antiviral activity of Australian tea tree oil and eucalyptus oil against herpes simplex virus in cell culture, 2001 Natural remedies for Herpes simplex, 2006 Randomized clinical study comparing Compeed cold sore patch to acyclovir cream 5% in the treatment of herpes simplex labialis, (..)
Since 2008, the Association of Chemistry and Pharmacy of Uruguay has played an active role in promoting a National Health Surveillance Agency, and in 2020 the government attempted to launch a similar agency but it ultimately failed.
Department of Health and Services (HHS) from 2001 to 2008. ARLINGTON, VA — July 7, 2025 — The Alliance for Safe Biologic Medicines (ASBM) today announced the retirement of longtime Board member Doug Badger, and the appointment of two new members to its Board of Directors: Cristina V.
Study design: Longitudinal analysis using health and retirement data The researchers used Health and Retirement Study biennial data—information collected and reported every two years—from 2008-2020 to identify respondents who originally chose Medicare coverage at age 65 or 66, and completed two successive surveys: one baseline survey that gauges initial (..)
The following chronic condition rates and symptom changes between 2007 and 2008 to 2021 and 2023 were identified: Childhood obesity rates among children ages 2 to 19 years old increased from 17% to 20.9%. between 2007 to 2008 and 2017 to 2020. Sleep apnea: 3.22 Eating disorder: 3.2 Anxiety: 3.06 Autism spectrum disorder: 2.62
Dr. Smith has been a faculty member at the University of Louisville School of Medicine since 2008 and previously served as chief medical officer of UofL Health-UofL Hospital from 2017 to 2019, the release said. Smith has served as chief medical officer since the health system’s inception in 2019, according to a June 27 news release.
At the time, in 2008, Cohen was director of the Cornea Service at Wills Eye Hospital in Philadelphia. But the next day, as she was pushing her hair back on that side of her head, she noticed a blister near the hairline. She knew immediately what it was: shingles.
million employed people (both within the health care field and outside) observed from 2008 to 2019. While other research has examined the incidence of mental health issues and suicide risk among physicians, the same isn’t necessarily true of other health care professions.
The ink had scarcely dried on new federal rules for enforcement of the Mental Health Parity and Addiction Equity Act of 2008 when U.S. health plans threatened potential legal action to block them.
Of the 65 laureates awarded the prize since 2008, 10 have gone on to receive the Nobel Prize. The $1 million Kavli Prize recognizes scientists for significant contributions and breakthroughs in astrophysics, nanoscience, and neuroscience once every two years. Read the rest…
Five studies co-authored by Tessier-Lavigne are now under the microscope for containing alleged altered images: a 1999 Cell study , a 2008 paper in the EMBO Journal, a 2003 Nature study, and two studies published in 2001 in Science.
based Reid Health since 2008, has taken an indefinite leave of absence. Craig Kent , MD, resigned as CEO of Charlottesville-based UVA Health and executive vice president for health affairs at the University of Virginia. Ted Wang was appointed CFO of Walnut Creek, Calif.-based based John Muir Health.
University of Michigan pediatric neurologist Vivian Cheung made a name for herself studying rare genetic diseases, and in 2008 — when she was on the faculty at the University of Pennsylvania — was hired as a Howard Hughes Medical Institute investigator, an honor for which she received $1 million a year over the next 12 years to further (..)
Patent & Trademark Office granted two more patents, but did not do so until 2008. The move meant that the company, which is now part of Bristol Myers Squibb, won several more years of valuable patent protection than it would have received had it applied for the extra patents when submitting its data to the FDA.
“That she took everything she knew about the pharmaceutical industry, having been part of it, and has really built a powerful advocacy for multiple myeloma patients, is remarkable,” said Tony Coles, who was CEO of Onyx Pharmaceuticals, a myeloma-focused biotech, from 2008 to 2014.
” Founded in 2008 by five scientists from MIT, Ginkgo was once one of the hottest venture-backed startups in Boston. The company said it intended to “regain compliance with [the] NYSE’s continued listing standards and is considering all available options to do so.”
Primary care staff need urgent support and training to care for people with food allergies, according to researchers who found that numbers have doubled since 2008. An analysis published in The Lancet Public Health said the largest rise had been seen in young children but the reasons behind the trend were not clear.
The price of a pack of 10mg tablets went from 70 pence in 2008 to £88 in 2016, according to the CMA, while a 20mg pack rose from £1.07 Before April 2008, the NHS was spending approximately £500,000 a year on hydrocortisone tablets, but that had swelled to £80 million by 2016. to £102.74.
As per the ICMR-INDIAB study conducted between October 17, 2008 and December 17, 2020, the overall weighted prevalence of diabetes was 11.4 per cent against the corresponding period last year (MAT August 2022).
According to one analysis of English newspapers , the number of articles stigmatising mental illness roughly halved between 2008 and 2016, while those challenging that stigma roughly doubled over the same period.
Epub 2008 Feb 15. References Bazan HA, Reiner E, Sumpio B. Management of bilateral phlegmasia cerulea dolens in a patient with subacute splenic laceration. Ann Vasc Dis. 2008;1(1):45-8. doi: 10.3400/avd.AVDcr07002. PMID: 23555338; PMCID: PMC3610218. Chaochankit W, Akaraborworn O. Phlegmasia Cerulea Dolens with Compartment Syndrome.
Calculation of 2010 IF of a journal To calculate the 2010 Impact Factor of a journal, we would look at the citations received by the journal in 2010 and divide that number by the total number of articles published in the journal in 2008 and 2009.
” Founded in 2008, Alteogen specialises in developing biologics, including ADCs, biobetters, and biosimilars. The company’s portfolio comprises clinical-stage long-acting therapeutic proteins and next-generation ADCs developed through its platform technologies, NexP-fusion and NexMab.
The alliance is with Roche Tissue Diagnostics (RTD), a unit of the Swiss pharma group that is concerned with the development of tissue-based tools to improve the diagnosis of cancer and grew out of Roche’s acquisition of Venta Medical Systems in 2008.
The system is Hapman’s first major product launch since 2008, following a year of intensive R&D that builds upon the company’s eight decades of tubular drag conveyor expertise.
” There will be no dramatic change in direction at Roche under the new CEO, according to Schwan, who was named CEO way back in 2008 and has been at the company throughout his entire career, joining the company in the early 1990s.
It suggests that rep-accessible physicians – those who met ore than 70% of reps who approach them – has dwindled from 80% in 2008 to 44% in 2018, even before the pandemic brought face-to-face contact to a standstill.
In 2008, CVS Caremark, a prescription benefit management company, signed on to use Microsoft’s HealthVault. The 2008 collaboration was on a much smaller scale compared to their current partnership. However, it is not the first alliance between the two companies. COVID accelerated coalitions.
offered feedback in response to the Administration’s proposed rule on updating requirements for the Mental Health Parity and Addiction Equity Act of 2008. Vizient, Inc.
Prior to joining Achieve Life Sciences in 2017, she served as OncoGenex’s executive vice president and chief medical officer since August 2008, and had been executive vice president and chief medical officer of OncoGenex Technologies Inc. from September 2005 to August 2008. The post Cytisinicline – the solution to stop smoking?
Using health records of 236,506 people with asthma between 2008 and […] The post Poorly controlled asthma contributing to greenhouse gas emissions appeared first on The Pharmacist. Most of the carbon footprint comes from over-reliance on reliever inhalers, a study published in Thorax and carried out by Astra Zeneca found.
Department of Health and Human Services from 2002-2008, including three years as Associate Deputy Secretary. A failure to do so will put patient health outcomes, and physician trust in these important medicines, in jeopardy. Michael Reilly served in the Office of the Secretary of the U.S. Read the oped at RealClearHealth
It’s a major change of direction for Boston-based Agios, which has been concentrating on the oncology market since its inception in 2008, bringing the Bristol Myers Squibb-partnered Tibsovo (ivosidenib) for IDH1-mutant acute myeloid leukaemia to the US market.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content